UnitedHealth Group CEO Andrew Witty Steps Down, Company Suspends 2025 Forecast
Published: May 13, 2025, 9:02 AM EDT
Updated: May 13, 2025, 10:47 AM EDT
By Annika Kim Constantino
In a surprising turn of events, UnitedHealth Group announced on Tuesday that its Chief Executive Officer, Andrew Witty, will be stepping down for "personal reasons." This unexpected announcement comes amid a challenging period for the healthcare giant, leading to a suspension of the company’s 2025 financial forecast. Following the news, UnitedHealth Group’s stock experienced a significant decline, dropping by nearly 10% in morning trading.
Transition in Leadership
Andrew Witty, who has been in the CEO role since 2021, will transition to a senior advisory position, providing guidance to his successor, Stephen Hemsley. Hemsley, who previously held the CEO position from 2006 to 2017, brings a wealth of experience back to the role after first joining UnitedHealth in 1997. "We are grateful for Andrew’s stewardship of UnitedHealth Group, especially during some of the most challenging times any company has ever faced," Hemsley stated in a press release.
Challenges Faced by UnitedHealth Group
Witty’s tenure was marked by numerous hurdles, including government investigations and a historic cyberattack that raised concerns over the company’s security measures. Furthermore, higher-than-expected medical costs and public backlash following the tragic murder of Brian Thompson, CEO of UnitedHealthcare, added to the company’s challenges over the past year. Witty, in December, had publicly acknowledged the flaws in the U.S. health system and stressed the need for reform, while also defending UnitedHealthcare’s practices.
Financial Forecast Suspended
The company’s decision to suspend its 2025 forecast is primarily attributed to elevated medical costs, particularly for new enrollees in its private Medicare plans. UnitedHealth has noted that the acceleration of care activities has surpassed expectations, leading to increased expenses that have impacted not only its financial outlook but also that of other key players in the health insurance sector.
Shares of competing firms, including CVS Health, Elevance Health, Humana, and Cigna, all saw declines following UnitedHealth’s announcement, reflecting a broader trend within the industry as it grapples with rising healthcare costs.
In recent months, UnitedHealth foreshadowed these difficulties, having already reduced its annual profit forecast, attributing the adjustments to higher medical costs associated with Medicare Advantage plans. The rising medical expenses came as many seniors returned to hospitals for delayed procedures that had been postponed during the COVID-19 pandemic.
Previous Performance and Future Outlook
Under Witty’s leadership, UnitedHealth faced its first earnings miss since 2008, an event that contributed to a sharp decline in the company’s stock value, erasing nearly $190 billion in market capitalization. Despite these setbacks, Stephen Hemsley expressed optimism for the future, citing significant growth opportunities. "UnitedHealth Group has tremendous opportunities to grow as we continue to help improve health care and to perform to our potential — and, in so doing, return to our long-term growth objective of 13 to 16 percent," Hemsley commented.
Looking ahead, UnitedHealth Group aims to rebound and expects to return to growth in 2026, marking a hopeful trajectory for shareholders and stakeholders alike.
As the company undergoes this leadership change, all eyes will be on Stephen Hemsley’s strategies to navigate the complex landscape of healthcare while addressing the challenges faced in recent years.
For more coverage and updates on UnitedHealth Group and the healthcare industry, stay tuned to Smart Money Mindset.
Share this article:
